Jaipur: Limited viral load testing capabilities are causing delays in treating hepatitis patients. The health department struggles to conduct viral load tests for about 45% of diagnosed hepatitis C ...
Hepatitis C virus (HCV) infection, which has been recognised as a cause of some autoimmune diseases, and which has been described as sometimes presenting with rheumatic manifestations ...
Hepatitis GB virus-C (HGBV-C)/hepatitis G virus (HGV) infection was investigated in 106 children ... Risk factors were identified in three patients, including blood transfusion and/or medical ...
Thus, IFN was effective in terminating viral replication in at least some patients with chronic HBV infection and ... have a major role in the treatment of chronic hepatitis B because of its ...
The definition and clinical use of common HBV serological markers are shown in Table 2. HBsAg is the hallmark of HBV infection and is the first serological marker to appear in acute hepatitis B.
GS-2121 is under clinical development by Gilead Sciences and currently in Phase I for Solid Tumor. According to GlobalData, Phase I drugs for Solid Tumor have a 69% phase transition success rate (PTSR ...
Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE American: NNVC) (the “Company”), comments on the many viruses that could cause pandemics that are going around already.
The scarring that occurs with cirrhosis is usually irreversible, but treatment can help manage ... exposure to hepatitis C, family history of autoimmune diseases, or other risk factors.
Maine CDC has identified an increase in new Human Immunodeficiency Virus (HIV) diagnoses in Penobscot County ... Respond quickly to potential HIV outbreaks to get prevention and treatment services to ...